While IL‐6 is usually considered to be triggered in response to type 1 or type 17 immune responses our results demonstrate a more complex picture where ILC2s may contribute to its release and its effects in severe asthma, though the mechanisms of this remain to be defined. Here, IL6 is linked to asthma.